Clinical research of Paroxetine combined with Amisulpride in the treatment of depression with psychotic symptoms
Lu We
Abstract
Lu We
Abstract
Objective:To observe the clinical efficacy of Amisulpride combined with in the treatment of depression with psychotic symptoms.Methods:A total of 82 patients identified by CCMD-3 for depression with psychotic symptoms were randomly divided into research group(41cases) and control group(41 cases),treated byAmisulpride plus Paroxetineand Paroxetine respectively.Hamilton Scale of depression(HAMD) was used to assess the clinical symptoms before and after the 1st,2nd,4th,8thweek of treatment;Adverse reaction of patients were evaluated with treatment emergence symptoms scale(TESS).Results:Effective rate of research group and control group was 85.4% and 65.9% respectively,there was significant difference(P0.01).HAMD scores of two groups had no significant difference in baseline(P0.05),and there was significant difference(P0.01)after treatment,which showed two therapy methods both can get curative effect;there were significant differences between the two groups in 2nd,4th and 8th weekend after treatment(P0.01).Conclusion:The treatment ofAmisulpride plus Paroxetinefor depression with psychotic symptoms is more safe and effective.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the clinical efficacy of Amisulpride combined with in the treatment of depression with psychotic symptoms.Methods:A total of 82 patients identified by CCMD-3 for depression with psychotic symptoms were randomly divided into research group(41cases) and control group(41 cases),treated byAmisulpride plus Paroxetineand Paroxetine respectively.Hamilton Scale of depression(HAMD) was used to assess the clinical symptoms before and after the 1st,2nd,4th,8thweek of treatment;Adverse reaction of patients were evaluated with treatment emergence symptoms scale(TESS).Results:Effective rate of research group and control group was 85.4% and 65.9% respectively,there was significant difference(P0.01).HAMD scores of two groups had no significant difference in baseline(P0.05),and there was significant difference(P0.01)after treatment,which showed two therapy methods both can get curative effect;there were significant differences between the two groups in 2nd,4th and 8th weekend after treatment(P0.01).Conclusion:The treatment ofAmisulpride plus Paroxetinefor depression with psychotic symptoms is more safe and effective.
Key concepts: Amisulpride, Hamd, Paroxetine, Depression (economics), Hamilton depression scale, Significant difference, Clinical efficacy, Medicine